AMITIZA (lubiprostone) capsules are indicated for the treatment of Chronic Idiopathic Constipation (CIC) in adults and Opioid-Induced Constipation (OIC) in adults with chronic, non-cancer pain (24 mcg twice daily). The effectiveness in patients with OIC taking diphenylheptane opioids (e.g., methadone) has not been established. AMITIZA is also indicated for Irritable Bowel Syndrome with Constipation (IBS-C) in women ≥ 18 years old (8 mcg twice daily).
Please take a moment to complete the registration form below to join AmitizaHCP. As an AmitizaHCP member, you will have access to tools and information and receive exclusive invitations to our newest programs and events for healthcare professionals. The information you provide will help us to quickly verify that you are a healthcare professional.
Questions? Visit AmitizaHCP program FAQs